article thumbnail

Advancing vaccine design: potential of peptide mimicry

Drug Target Review

1 The study reveals a novel bioinformatic approach and tool that holds the potential to empower researchers in designing vaccines capable of inducing a stronger immune response. Elsevier; 2020 [cited 2023 Jul 25]. Since December 2019, SARS-CoV-2 (COVID-19) infection has become a worldwide urgent public health concern.

Vaccine 98
article thumbnail

Case study: NCI’s Molecular Targets Platform

The Open Targets Blog

 To address this disparity, the USA’s Research to Accelerate Cures and Equity (RACE) for Children Act as of 2020 requires any company designing a clinical trial for an antineoplastic therapy to include a pediatric trial component if the gene target is on the FDA’s Pediatric Molecular Target Lists (PMTL).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

United Therapeutics Corporation To Report Third Quarter 2020 Financial Results Before The Market Opens On Wednesday, October 28, 2020

The Pharma Data

21, 2020 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2020 financial results before the market opens on Wednesday, October 28, 2020. United Therapeutics will host a teleconference on Wednesday, October 28, 2020 , at 9:00 a.m. SILVER SPRING, Md.

article thumbnail

Vitamin A and its role in psychiatric and other disorders

Drug Target Review

While there has been some epidemiological support for vitamin A or deficiency in observational studies, we supported this role for the vitamin in schizophrenia using genetic approaches back in 2020. Murray has used his expertise in bioinformatics to establish an internationally recognised laboratory specialising in complex trait genomics.

article thumbnail

Unlocking the potential of natural products in drug discovery

Drug Target Review

Between 2000 and 2020, approximately 30 percent of the newly introduced small molecule drugs were derived from natural products. Her major focus has been untargeted metabolomics method development and bioinformatics solutions for structure elucidation. References Newman DJ, Cragg GM.

article thumbnail

United Therapeutics Corporation Reports Third Quarter 2020 Financial Results

The Pharma Data

28, 2020 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended September 30, 2020. ” THIRD QUARTER 2020 FINANCIAL RESULTS. .” ” THIRD QUARTER 2020 FINANCIAL RESULTS. 2020. 2020.

FDA 40
article thumbnail

Egle Therapeutics Identifies First Novel Regulatory T-cell Targets in Research Alliance with Takeda

The Pharma Data

26, 2020 10:30 UTC. In the course of the strategic research alliance that was announced in June 2020, Egle will validate novel tumor-infiltrating regulatory T-cell (Treg) targets against which Takeda will develop potential therapies. About Egle Therapeutics.